Altium Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,751
| Closed | -$1.4M | – | 151 |
|
|
2021
Q4 | $1.4M | Sell |
11,751
-12,637
| -52% | -$1.5M | 0.38% | 80 |
|
|
2021
Q3 | $4.85M | Hold |
24,388
| – | – | 1.27% | 31 |
|
|
2021
Q2 | $4.24M | Buy |
24,388
+13,678
| +128% | +$2.38M | 0.98% | 36 |
|
|
2021
Q1 | $2.12M | Hold |
10,710
| – | – | 0.59% | 72 |
|
|
2020
Q4 | $2.11M | Buy |
+10,710
| New | +$2.11M | 0.79% | 53 |
|